Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | THRB | P10828 | 3/20 | 0.54 |
| ▸ | CASP7 | P55210 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | CASP1 | P29466 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | TNF | P01375 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL999012 | 0.87 | KDM4E (0.63) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL12640756 | 0.85 | KDM4E (0.57) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL5424439 | 0.84 | KDM4E (0.70) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL4997223 | 0.83 | KDM4E (0.56) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5430842 | 0.82 | KDM4E (0.68) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL17774713 | 0.81 | ALDH1A1 (0.64) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL1551912 | 0.81 | KDM4E (0.50) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL743743 | 0.81 | KDM4E (0.56) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL26963250 | 0.81 | KDM4E (0.50) | KDM4EKMT2ATDP1MEN1ALDH1A1 | |
| SCHEMBL11881146 | 0.79 | KDM4E (0.79) | KDM4EKMT2ATDP1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719381-A1 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. (TW) | 2026-04-08 | — | — | EP | disclosed |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | TRIPARTITE THERAPEUTICS INC. (TW) | 2025-01-30 | — | — | US | disclosed |
| US-5859182-A | Fluorine-containing polyquinazolone polymer and separation membrane using the same | NITTO DENKO CORPORATION (JP) | 1999-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | CD274, SELPLG, PDCD1LG2 | KDM4E 4142/4885KMT2A 4242/4885TDP1 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.